Annual Cash & Cash Equivalents
$97.47 M
+$17.97 M+22.60%
December 31, 2023
Summary
- As of February 22, 2025, FLGT annual cash & cash equivalents is $97.47 million, with the most recent change of +$17.97 million (+22.60%) on December 31, 2023.
- During the last 3 years, FLGT annual cash & cash equivalents has risen by +$10.05 million (+11.49%).
- FLGT annual cash & cash equivalents is now -40.89% below its all-time high of $164.89 million, reached on December 31, 2021.
Performance
FLGT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$58.04 M
-$7.07 M-10.86%
September 30, 2024
Summary
- As of February 22, 2025, FLGT quarterly cash and cash equivalents is $58.04 million, with the most recent change of -$7.07 million (-10.86%) on September 30, 2024.
- Over the past year, FLGT quarterly cash and cash equivalents has dropped by -$26.03 million (-30.96%).
- FLGT quarterly cash and cash equivalents is now -83.56% below its all-time high of $353.07 million, reached on March 31, 2022.
Performance
FLGT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
FLGT Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +22.6% | -31.0% |
| 3 y3 years | +11.5% | -27.0% |
| 5 y5 years | +1347.0% | -27.0% |
FLGT Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -40.9% | +22.6% | -83.6% | +6.2% |
| 5 y | 5-year | -40.9% | +714.6% | -83.6% | +2287.6% |
| alltime | all time | -40.9% | >+9999.0% | -83.6% | >+9999.0% |
Fulgent Genetics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $58.04 M(-10.9%) |
| Jun 2024 | - | $65.11 M(+19.1%) |
| Mar 2024 | - | $54.68 M(-43.9%) |
| Dec 2023 | $97.47 M(+22.6%) | $97.47 M(+15.9%) |
| Sep 2023 | - | $84.08 M(+44.1%) |
| Jun 2023 | - | $58.35 M(-11.8%) |
| Mar 2023 | - | $66.17 M(-16.8%) |
| Dec 2022 | $79.51 M(-51.8%) | $79.51 M(-52.9%) |
| Sep 2022 | - | $168.77 M(+21.6%) |
| Jun 2022 | - | $138.78 M(-60.7%) |
| Mar 2022 | - | $353.07 M(+114.1%) |
| Dec 2021 | $164.89 M(+88.6%) | $164.89 M(-23.3%) |
| Sep 2021 | - | $214.88 M(+113.9%) |
| Jun 2021 | - | $100.46 M(-33.7%) |
| Mar 2021 | - | $151.46 M(+73.2%) |
| Dec 2020 | $87.43 M | $87.43 M(+64.9%) |
| Sep 2020 | - | $53.03 M(+2081.4%) |
| Jun 2020 | - | $2.43 M(-73.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $9.30 M(-22.3%) |
| Dec 2019 | $11.96 M(+77.6%) | $11.96 M(-41.7%) |
| Sep 2019 | - | $20.52 M(+123.9%) |
| Jun 2019 | - | $9.16 M(+73.3%) |
| Mar 2019 | - | $5.29 M(-21.5%) |
| Dec 2018 | $6.74 M(+3.8%) | $6.74 M(-20.7%) |
| Sep 2018 | - | $8.49 M(+132.3%) |
| Jun 2018 | - | $3.65 M(-30.7%) |
| Mar 2018 | - | $5.27 M(-18.7%) |
| Dec 2017 | $6.49 M(-17.8%) | $6.49 M(-31.5%) |
| Sep 2017 | - | $9.48 M(-17.4%) |
| Jun 2017 | - | $11.47 M(+70.4%) |
| Mar 2017 | - | $6.73 M(-14.7%) |
| Dec 2016 | $7.90 M(+1514.9%) | $7.90 M(-3.8%) |
| Sep 2016 | - | $8.21 M(-48.9%) |
| Jun 2016 | - | $16.06 M(+3184.3%) |
| Dec 2015 | $489.00 K(+184.3%) | $489.00 K |
| Dec 2014 | $172.00 K | - |
FAQ
- What is Fulgent Genetics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Fulgent Genetics?
- What is Fulgent Genetics annual cash & cash equivalents year-on-year change?
- What is Fulgent Genetics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Fulgent Genetics?
- What is Fulgent Genetics quarterly cash and cash equivalents year-on-year change?
What is Fulgent Genetics annual cash & cash equivalents?
The current annual cash & cash equivalents of FLGT is $97.47 M
What is the all time high annual cash & cash equivalents for Fulgent Genetics?
Fulgent Genetics all-time high annual cash & cash equivalents is $164.89 M
What is Fulgent Genetics annual cash & cash equivalents year-on-year change?
Over the past year, FLGT annual cash & cash equivalents has changed by +$17.97 M (+22.60%)
What is Fulgent Genetics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of FLGT is $58.04 M
What is the all time high quarterly cash and cash equivalents for Fulgent Genetics?
Fulgent Genetics all-time high quarterly cash and cash equivalents is $353.07 M
What is Fulgent Genetics quarterly cash and cash equivalents year-on-year change?
Over the past year, FLGT quarterly cash and cash equivalents has changed by -$26.03 M (-30.96%)